• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨桥蛋白的过表达促进肝癌对顺铂治疗的耐药性。

Overexpression of osteopontin promotes resistance to cisplatin treatment in HCC.

作者信息

Ding Kun, Fan Lu, Chen Shijun, Wang Yanna, Yu Haifeng, Sun Yanni, Yu Jiguang, Wang Li, Liu Xiangzhong, Liu Youde

机构信息

Department of Liver Diseases, Jinan Infectious Disease Hospital, Shandong University School of Medicine, Jian, Shandong 250000, P.R. China.

Yantai Infectious Disease Hospital, Yantai, Shandong 264001, P.R. China.

出版信息

Oncol Rep. 2015 Dec;34(6):3297-303. doi: 10.3892/or.2015.4306. Epub 2015 Sep 23.

DOI:10.3892/or.2015.4306
PMID:26397192
Abstract

Osteopontin (OPN) is a multi-functional cytokine involved in cell survival, migration and adhesion. Increasing evidence has elucidated its role in tumorigenesis, progression and metastasis. However, the role of OPN in chemoresistance of human hepatocellular carcinoma (HCC) has not yet been clarified. In the present study, we examined the expression of OPN in human HCC samples before and after cisplatin-treatment, the results showed that OPN was significantly increased in cisplatin-resistant specimens. We then studied the effect of cisplatin on OPN expression in HCC cells, after exposure to cisplatin, the expression of OPN in HCC cells was elevated compared to control cells. We also found that PI3K/AKT signaling pathway was also activated by cisplatin and this effect was induced by the OPN pathway. To study the effect of OPN on chemoresistance, HCC cells were treated with cisplatin along with OPN. Incubation with OPN enchanced the chemoresistance of HCC cells to cisplatin. In contrast, blockage of OPN pathway promoted the chemosensitivity of HCC cells to cisplatin. Our results suggest that OPN enhanced chemoresistance of cisplatin in HCC cells by activating PI3K/AKT signaling pathway, blocking the OPN pathway might be a novel way to overcome the disease.

摘要

骨桥蛋白(OPN)是一种多功能细胞因子,参与细胞存活、迁移和黏附。越来越多的证据阐明了其在肿瘤发生、进展和转移中的作用。然而,OPN在人类肝细胞癌(HCC)化疗耐药中的作用尚未明确。在本研究中,我们检测了顺铂治疗前后人类HCC样本中OPN的表达,结果显示顺铂耐药标本中OPN显著增加。然后我们研究了顺铂对HCC细胞中OPN表达的影响,暴露于顺铂后,HCC细胞中OPN的表达相对于对照细胞升高。我们还发现PI3K/AKT信号通路也被顺铂激活,且这种作用是由OPN通路诱导的。为了研究OPN对化疗耐药的影响,HCC细胞用顺铂和OPN共同处理。与OPN孵育增强了HCC细胞对顺铂的化疗耐药性。相反,阻断OPN通路促进了HCC细胞对顺铂的化疗敏感性。我们的结果表明,OPN通过激活PI3K/AKT信号通路增强了HCC细胞对顺铂的化疗耐药性,阻断OPN通路可能是克服该疾病的一种新方法。

相似文献

1
Overexpression of osteopontin promotes resistance to cisplatin treatment in HCC.骨桥蛋白的过表达促进肝癌对顺铂治疗的耐药性。
Oncol Rep. 2015 Dec;34(6):3297-303. doi: 10.3892/or.2015.4306. Epub 2015 Sep 23.
2
Osteopontin induces autophagy to promote chemo-resistance in human hepatocellular carcinoma cells.骨桥蛋白诱导自噬以促进人肝癌细胞的化疗耐药性。
Cancer Lett. 2016 Dec 28;383(2):171-182. doi: 10.1016/j.canlet.2016.09.033. Epub 2016 Oct 1.
3
Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.骨桥蛋白通过整合素-NF-κB-HIF-1α 信号通路促进肝癌细胞形成癌干细胞样表型。
Oncotarget. 2015 Mar 30;6(9):6627-40. doi: 10.18632/oncotarget.3113.
4
Correlation and prognostic value of osteopontin and Bcl-2 in hepatocellular carcinoma patients after curative resection.骨桥蛋白和 Bcl-2 在肝癌患者根治性切除术后的相关性及其预后价值。
Oncol Rep. 2013 Dec;30(6):2795-803. doi: 10.3892/or.2013.2737. Epub 2013 Sep 19.
5
C-C chemokine receptor type 1 mediates osteopontin-promoted metastasis in hepatocellular carcinoma.C-C趋化因子受体1介导骨桥蛋白促进的肝癌转移。
Cancer Sci. 2018 Mar;109(3):710-723. doi: 10.1111/cas.13487. Epub 2018 Feb 13.
6
The role of CD29-ILK-Akt signaling-mediated epithelial-mesenchymal transition of liver epithelial cells and chemoresistance and radioresistance in hepatocellular carcinoma cells.CD29-整合素连接激酶-Akt信号传导介导的肝上皮细胞上皮-间质转化及肝癌细胞化疗耐药和放疗抵抗的作用
Med Oncol. 2015 May;32(5):141. doi: 10.1007/s12032-015-0595-x. Epub 2015 Mar 25.
7
Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression.骨桥蛋白通过上调 MMP-2 和 uPA 的表达促进肝癌侵袭。
Mol Biol Rep. 2011 Aug;38(6):3671-7. doi: 10.1007/s11033-010-0481-8. Epub 2010 Nov 23.
8
Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.骨桥蛋白下调通过涉及 MMP-2 和 uPA 的机制抑制肝癌细胞转移。
Oncol Rep. 2011 Mar;25(3):803-8. doi: 10.3892/or.2010.1116. Epub 2010 Dec 21.
9
Transactivation of human osteopontin promoter by human T-cell leukemia virus type 1-encoded Tax protein.人 T 细胞白血病病毒 1 编码的 Tax 蛋白对人骨桥蛋白启动子的反式激活。
Leuk Res. 2010 Jun;34(6):763-8. doi: 10.1016/j.leukres.2009.08.028. Epub 2009 Sep 19.
10
Luteolin induces caspase-dependent apoptosis via inhibiting the AKT/osteopontin pathway in human hepatocellular carcinoma SK-Hep-1 cells.木犀草素通过抑制 AKT/骨桥蛋白通路诱导人肝癌 SK-Hep-1 细胞中的细胞凋亡。
Life Sci. 2018 Sep 15;209:259-266. doi: 10.1016/j.lfs.2018.08.025. Epub 2018 Aug 11.

引用本文的文献

1
Resveratrol enhances the antiliver cancer effect of cisplatin by targeting the cell membrane protein PLA2.白藜芦醇通过作用于细胞膜蛋白PLA2增强顺铂的抗肝癌作用。
Front Oncol. 2024 Sep 24;14:1453164. doi: 10.3389/fonc.2024.1453164. eCollection 2024.
2
Osteopontin: A Key Multifaceted Regulator in Tumor Progression and Immunomodulation.骨桥蛋白:肿瘤进展和免疫调节中的关键多面调节因子。
Biomedicines. 2024 Jul 9;12(7):1527. doi: 10.3390/biomedicines12071527.
3
SPP1 expression indicates outcome of immunotherapy plus tyrosine kinase inhibition in advanced renal cell carcinoma.
SPP1 表达预示晚期肾细胞癌免疫治疗联合酪氨酸激酶抑制的疗效。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2350101. doi: 10.1080/21645515.2024.2350101. Epub 2024 May 13.
4
Osteopontin and Cancer: Insights into Its Role in Drug Resistance.骨桥蛋白与癌症:对其在耐药性中作用的见解
Biomedicines. 2023 Jan 12;11(1):197. doi: 10.3390/biomedicines11010197.
5
The Effects of Qinghao-Kushen and Its Active Compounds on the Biological Characteristics of Liver Cancer Cells.青蒿-苦参及其活性成分对肝癌细胞生物学特性的影响
Evid Based Complement Alternat Med. 2022 Jun 10;2022:8763510. doi: 10.1155/2022/8763510. eCollection 2022.
6
Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma-What Do We Already Know.肝细胞癌和胆管癌的生物标志物与遗传标志物——我们已经了解了什么。
Cancers (Basel). 2022 Mar 15;14(6):1493. doi: 10.3390/cancers14061493.
7
EMT and Inflammation: Crossroads in HCC.急诊医疗技术员和炎症:HCC 的十字路口。
J Gastrointest Cancer. 2023 Mar;54(1):204-212. doi: 10.1007/s12029-021-00801-z. Epub 2022 Jan 12.
8
circMRPS35 promotes malignant progression and cisplatin resistance in hepatocellular carcinoma.环状 RNA MRPS35 促进肝癌的恶性进展和顺铂耐药性。
Mol Ther. 2022 Jan 5;30(1):431-447. doi: 10.1016/j.ymthe.2021.08.027. Epub 2021 Aug 25.
9
Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway.华蟾酥毒基通过抑制IL-6-骨桥蛋白-STAT3信号通路抑制骨肉瘤癌细胞的特性。
Drug Des Devel Ther. 2019 Dec 4;13:4075-4090. doi: 10.2147/DDDT.S224312. eCollection 2019.
10
Accounting for tumor heterogeneity when using CRISPR-Cas9 for cancer progression and drug sensitivity studies.当使用 CRISPR-Cas9 进行癌症进展和药物敏感性研究时,需要考虑肿瘤异质性。
PLoS One. 2018 Jun 13;13(6):e0198790. doi: 10.1371/journal.pone.0198790. eCollection 2018.